Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
11C-Choline PET/CT in Lymphangioleiomyomatosis
NCT05087134Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Nov 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of choline C 11 in lymphangioleiomyomatosis (LAM), sponsored by Peking Union Medical College Hospital. Primary endpoint: Standardized uptake value at 2 years. Status: unknown.
02
Drugs
choline C 11
03
Conditions
lymphangioleiomyomatosis (LAM)
Beyond the preview
Go deeper on NCT05087134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05087134.